Previous close | 109.57 |
Open | 109.84 |
Bid | 110.17 x 300 |
Ask | 110.32 x 500 |
Day's range | 109.10 - 112.15 |
52-week range | 87.43 - 132.76 |
Volume | |
Avg. volume | 1,445,750 |
Market cap | 24.63B |
Beta (5Y monthly) | 1.40 |
PE ratio (TTM) | 13.10 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.96 (4.50%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), today reported its financial results for the first quarter of 2024. The earnings release can be found on the firm's website at troweprice.com/newsroom.
New York, New York, April 15, 2024 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a unitranche facility supporting the refinancing of Acentra Health (“Acentra”), a portfolio company of Carlyle. Acentra is a leading provider of technology products and services to government healthcare agencies that are essential to administering Medicaid, Medicare and other health programs at the federal and state level, including claims processing, enrollm
T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), today reported preliminary month-end assets under management of $1.54 trillion as of March 31, 2024. Preliminary net outflows were $1.2 billion for March 2024 and $8.0 billion for the quarter-ended March 2024.